Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2933
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04634149 | A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment | ||
| NCT04735978 | Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid Tumours | ||
| NCT00688493 | Effects of Single Oral Dose Dapagliflozin QT Study | ||
| NCT03692325 | Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia | ||
| NCT04410445 | Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence | ||
| NCT00410072 | Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B | ||
| NCT02713867 | A Dose Frequency Optimization,Trial of Nivolumab 240 mg Every 2 Weeks vs Nivolumab 480 mg Every 4 Weeks in Subjects With Advanced or Metastatic Non-small Cell Lung Cancer Who Received Up to 12 Months of Nivolumab at 3 mg/kg or 240 mg Every 2 Weeks | ||
| NCT04349267 | Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid Tumors | ||
| NCT06504615 | Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France | ||
| NCT01142726 | Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis | ||
| NCT05980949 | Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3) | ||
| NCT01058083 | Safety Study of BMS-770767 in Subjects With Hypercholesterolemia | ||
| NCT03660072 | Postmarketing Study of Empliciti in Korean Patients With Multiple Myeloma | ||
| NCT00136539 | Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | ||
| NCT02100228 | Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) | ||
| NCT03502330 | APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma | ||
| NCT06869551 | A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis | ||
| NCT04671953 | Effect of BMS-986165 on the Blood Levels of Metformin | ||
| NCT00094653 | MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma | ||
| NCT05946941 | A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome | ||
| NCT06725537 | Comprehensive Demographics and Clinical Profile of NSCLC Patients | ||
| NCT02109666 | Long Term Experience With Abatacept in Routine Clinical Practice | ||
| NCT01120457 | First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers | ||
| NCT00399685 | Drug Interaction - Oral Contraceptive | ||
| NCT07141563 | A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC | ||
| NCT03943147 | An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis | ||
| NCT04457284 | Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer | ||
| NCT04322955 | CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition | ||
| NCT03505515 | Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer | ||
| NCT03558087 | Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing | ||
| NCT00324155 | Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma | ||
| NCT03196206 | Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment | ||
| NCT02341638 | Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects | ||
| NCT03276429 | Lung Cancer Registry for Lung Cancer Patients | ||
| NCT05838781 | DeteCtiON and Stroke PreventIon by MoDEl ScRreenING for Atrial Fibrillation | ||
| NCT06452329 | A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer | ||
| NCT00978731 | Chronic Myelogenous Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemic Study | ||
| NCT01018745 | Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan | ||
| NCT01086267 | Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal Cancer | ||
| NCT00964912 | Single Dose Study of BMS-820836 | ||
| NCT00001065 | A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole | ||
| NCT00359476 | A Study of Vinflunine in Patients With Gastric Cancer | ||
| NCT03192215 | AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke | ||
| NCT03953235 | A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens | ||
| NCT01471717 | Study to Evaluate the Pharmacokinetics and Safety of INX-08189 Administered With VictrelisTM in Healthy Subjects | ||
| NCT00546715 | A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects | ||
| NCT05891249 | A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India | ||
| NCT00971308 | Multiple Dose Study In Treatment Naive Subjects Infected With Hepatitis C Virus | ||
| NCT06924255 | An 8-week Open-label Study of an Accelerated and Slower Switching to Xanomeline/Trospium Following Atypical Antipsychotic Treatment in Participants With Schizophrenia | ||
| NCT02427126 | Apixaban for Treatment of Embolic Stroke of Undetermined Source |
